Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Ultiva
Active Ingredient(s): Remifentanil hydrochloride 1.1mg equivalent to 1mg remifentanil
Dosage Form: Powder for injection
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Pharmacia & Upjohn NV/SA, Puurs, Belgium
Product: Ultiva
Active Ingredient(s): Remifentanil hydrochloride 2.2mg equivalent to 2mg remifentanil
Dosage Form: Powder for injection
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Pharmacia & Upjohn NV/SA, Puurs, Belgium
Product: Ultiva
Active Ingredient(s): Remifentanil hydrochloride 5.5mg equivalent to 5mg remifentanil
Dosage Form: Powder for injection
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Pharmacia & Upjohn NV/SA, Puurs, Belgium
Dated this 1st day of November 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).